Cardiac Diagnostics

This channel includes news, videos, podcasts and other content on new technology innovations for cardiac diagnostic systems and techniques. This includes laboratory testing, blood tests including troponin testing, electrocardiogram (ECG) systems, point of care testing systems, genetic testing, cardiac patient monitoring devices including wearable sensors, and studies showing new ways to diagnose heart diseases.

Videos | Cardiac Imaging | August 12, 2020
Advanced visualization company Medis recently purchased Advanced Medical Imaging Development S.r.l. (AMID), which...
Part of a CDC inforgraphic on MIS-C based on reports from U.S. cases March-May 2020.[2] The full inforgraphic can be found at https://www.cdc.gov/coronavirus/2019-ncov/covid-data/infographic-mis-c.html #COVID19

Part of a CDC inforgraphic on MIS-C based on reports from U.S. cases March-May 2020.[2] The full inforgraphic can be found at https://www.cdc.gov/coronavirus/2019-ncov/covid-data/infographic-mis-c.html

News | Coronavirus (COVID-19) | August 07, 2020
August 7, 2020 — The National Institutes of Health (NIH) announced research funding to encourage the development of...
Wearable Sensors and AI App Used to Remotely Monitor Heart Failure Patients in NorthShore Health System. Carnegie Mellon University, Northshore and physIQ launch Study of monitoring technology for high-risk cardiac and surgical patients.
News | Remote Monitoring | August 05, 2020
August 5, 2020 – NorthShore University HealthSystem , Carnegie Mellon University and physIQ are collaborating on a...
A team from Purdue University developed self-powered wearable triboelectric nanogenerators with polyvinyl alcohol-based contact layers for monitoring cardiovascular health.

A team from Purdue University developed self-powered wearable triboelectric nanogenerators with polyvinyl alcohol-based contact layers for monitoring cardiovascular health.

News | Wearables | July 22, 2020
July 22, 2020 — A team from Purdue University has developed self-powered wearable triboelectric nanogenerators (TENGs)...
VitalSight is a HIPAA-compliant, Medicare-reimbursable home blood pressure monitoring solution that generally comes at no cost to the patient, depending on their coverage. The kit typically includes a digital blood pressure monitor with cuff, weight scale and digital medication tracker, as well as a data hub.
News | Hypertension | July 15, 2020
July 15, 2020 – Omron Healthcare Inc. and Mount Sinai Health System, New York City’s largest academic medical system,...
The Linq II implantable cardiac monitor (ICM) system delivers improved device longevity compared to other ICMs and enhanced accuracy to correctly detect abnormal heart rhythms, simplifying the diagnosis and monitoring of patients. The new devices allows continuous cardiac monitoring for up to 4.5 years.

The Linq II implantable cardiac monitor (ICM) system delivers improved device longevity compared to other ICMs and enhanced accuracy to correctly detect abnormal heart rhythms, simplifying the diagnosis and monitoring of patients. The new devices allows continuous cardiac monitoring for up to 4.5 years.

News | Implantable Cardiac Monitor (ICM) | July 07, 2020
July 7, 2020 – Medtronic announced it received U.S. Food and Drug Administration (FDA) clearance and European CE mark...
Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosai

Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosaic pattern with a bronchocentric distribution to the GGO (white arrow, d) involving both central and peripheral lung parenchyma with pleural effusions (black small arrow, d). image courtesy of Radiological Society of North America

Feature | Coronavirus (COVID-19) | June 30, 2020
In recent weeks, a multisystem hyperinflammatory condition has emerged in children in association with prior exposure...
First ICM device with remote programming paired with dual-stage arrhythmia detection algorithm
News | Implantable Cardiac Monitor (ICM) | June 29, 2020
June 29, 2020 — Boston Scientific received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LUX-Dx ...
Bystanders using a Philips HeartStart AED for a patient in sudden cardiac arrest.

Bystanders using a Philips HeartStart AED for a patient in sudden cardiac arrest.

News | Defibrillator Monitors | June 23, 2020
June 23, 2020 — Philips announced the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for...
A PCR genetic test nasal swab being taken from a patient to test if they are infected with COVID-19. While used as the primary test to diagnose coronavirus, up to 20 percent of patients will test negative even eight days after infection. Getty Images

A PCR genetic test nasal swab being taken from a patient to test if they are infected with COVID-19. While used as the primary test to diagnose coronavirus, up to 20 percent of patients will test negative even eight days after infection. Getty Images

News | Coronavirus (COVID-19) | June 10, 2020
June 10, 2020 — In a new study, Johns Hopkins researchers found that testing people for SARS-CoV-2 (COVID-19) too early...
Russian interventional cardiologist Alexey Pankov in full personal protective equipment (PPE) for a cath lab procedure in Moscow during the COVID-19 era. Right, an image of the COVID-19 virus from the National Institutes of Health (NIH).

Russian interventional cardiologist Alexey Pankov in full personal protective equipment (PPE) for a cath lab procedure in Moscow during the COVID-19 era. Right, an image of the COVID-19 virus from the National Institutes of Health (NIH). Novel coronavirus has turned out to have a sizable amount of cardiovascular involvement.

Feature | Coronavirus (COVID-19) | June 05, 2020 | Dave Fornell, Editor
It was originally thought novel coronavirus (COVID-19, SARS-CoV-2) was primarily a respiratory disorder, but as larger...
Societies Issue Guide to Safely Resume Cardiovascular Procedures, Diagnostic Tests. #COVID19 #SARScov2
Feature | Cardiovascular Business | June 03, 2020
The American College of Cardiology (ACC) together with other North American cardiovascular societies issued a framework...
Videos | Coronavirus (COVID-19) | May 28, 2020
Interview with Andrew D. Krahn, M.D.,FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of...
HRS study finds Frequent Coffee Consumption Lowers Chance of Arrhythmias. #HRS #HRS20 Heartrhythm20
News | EP Lab | May 28, 2020
May 28, 2020 – A recent study revealed that drinking a couple of cups of coffee per day does not lead to a greater risk...
Texas Cardiac Arrhythmia Institute Uses Abbott's ID Now COVID-19 Rapid Test to Screen EP Patients. The center compared conventional PCR testing to the rapid test and found it was very accurate. #COVID19 #SARScov2
News | Coronavirus (COVID-19) | May 28, 2020
May 28, 2020 — As hospitals begin reopening to elective exams and procedures amid the COVID-19 pandemic, they need to...